S

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark S was filed as Figurative mark on 01/16/2020 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Letters or numerals forming geometrical figures, written or typographical matter in perspective #Letters presenting a special form of writing #One letter

Trademark Details Last update: August 4, 2023

Trademark form Figurative mark
File reference 1548395
Countries Australia Canada China em United Kingdom Japan Mexico
Base trademark US No. , August 3, 2024
Application date January 16, 2020
Expiration date January 16, 2030

Trademark owner

9924 West 74th Street
Eden Prairie MN 55344
US

Trademark representatives

P.O. Box 2910 Minneapolis MN 55402 US

goods and services

01 Reagents for scientific or medical research use; photoreactive chemical coating compositions for industrial, including medical, use; chemicals for use in the manufacture of medical device coatings; chemical preparations for scientific purposes used for blocking and antibody dilution in blotting applications; chemical preparations for scientific purposes for use with analytical procedures in research and diagnostic applications; liquid preparation for use in stabilizing reagents employed in immunoassays; chemical solutions for stabilizing biological molecules for scientific or medical research use and for use in the manufacture of medical devices; chemicals, namely, a chemical solution for use in preserving analytical reagents for scientific and research use; photoreactive chemical coating compositions for general industrial use, and for use in the manufacture of medical devices and diagnostic test devices; diagnostic assay kits composed primarily of DNA assay substrates and reagents; diagnostic assay components, namely, DNA assay substrates and reagents; chemicals for use in the manufacture of coatings for medical devices; chemicals for use in the manufacture of drug eluting coatings; chemicals for use in the manufacture of drug delivery coatings; biopolymer based coatings for use in the manufacture of implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices; chemical coatings used in the manufacture of medical devices
02 Medical device coatings; coatings for biological and surgical implants, for providing a lubricious and biocompatible surface, sold separately from the implants; chemical coatings for medical devices, for delivery of a wide range of pharmaceuticals, sold separately from the medical devices; medical device coatings for coronary, peripheral, neurovascular or heart devices; lubricious coatings for medical devices; hemocompatible coatings for medical devices
05 Chemical preparations for medical purposes, namely, for coating medical devices and delivering medicine for the treatment of vascular disease; drug delivery matrices consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical reagents for medical or veterinary purposes
09 Microarray slides for scientific, laboratory or medical research use; polymer coated beads, membranes, plates and surfaces that immobilize or attach target biomolecules to the surface while preventing absorption of unwanted biomolecules to the surface, for laboratory or scientific use
10 Medical devices and apparatus, namely, catheters and drug eluting balloon catheters; medical devices, namely, stents that contain and deliver a wide range of pharmaceuticals; orthopedic implants, ocular implants and surgical implants comprised of artificial materials, coated with material for the delivery of a wide range of pharmaceuticals; medical stents and other implantable medical devices, coated with material containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices; medical devices, namely, coronary stent systems; medical devices, namely, angioplasty catheters; medical devices, namely, medical device access systems; medical devices, namely, chronic total occlusion devices; medical devices, namely, embolic protection device; medical devices, namely, hemostasis introducer sheath; medical devices, namely, interventional micro-catheter
40 Surface treatment services for stabilizing proteins upon enzyme immunoassay product components of others; consulting about custom manufacturing medical and surgical devices; consulting in the field of medical devices related to manufacturing coaxial guide catheters

Trademark history

Date Document number Area Entry
July 26, 2023 2023/31 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 31, 2022 2022/14 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 22, 2021 2022/2 Gaz CA Rejection
December 8, 2021 2021/49 Gaz MX Rejection
September 16, 2021 2021/37 Gaz JP Rejection
February 22, 2021 2021/8 Gaz US RAW: Division or Merger of Basic Registration
January 25, 2021 2021/4 Gaz EM Rejection
January 12, 2021 2021/2 Gaz AU Rejection
January 4, 2021 2021/1 Gaz CN Rejection
December 16, 2020 2020/51 Gaz GB Rejection
January 16, 2020 2020/34 Gaz US Registration

ID: 141548395